Back to search

Article

Rock inhibitors target <i>SRSF2</i> leukemia by disrupting cell mitosis and nuclear morphology

2022-02-17

Abstract excerpt

Spliceosome machinery mutations are common early mutations in myeloid malignancies, however effective targeted therapies against them are still lacking. In the current study, we used an in vitro high-throughput drug screen among four different isogenic cell lines and identified ROCK inhibitors (ROCKi) as selective inhibitors of SRSF2 mutants. ROCKi targeted SRSF2 Mut primary human samples in a xenografts model...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
46d94059-f14a-55ef-9b0a-c043eaa985e3
DOI
10.1101/2022.02.15.479934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rock inhibitors target <i>SRSF2</i> leukemia by disrupting cell mitosis and nuclear morphologyDOI 10.1101/2022.02.15.479934
Select a neighboring publication to make it the new centre.